Clinical Trial Update: Study on the Influence of Electroconvulsive Therapy (ECT) on Homocysteine Levels [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing how electroconvulsive therapy (ECT) affects homocysteine levels in patients with depressive disorders; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED